{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:24:05Z","timestamp":1795119845061,"version":"4.10.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92057209"],"award-info":[{"award-number":["92057209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabolic reprogramming evolves during cancer initiation and progression. However, thorough understanding of metabolic evolution from preneoplasia to lung adenocarcinoma (LUAD) is still limited. Here, we perform large-scale targeted metabolomics on resected lesions and plasma obtained from invasive LUAD and its precursors, and decipher the metabolic trajectories from atypical adenomatous hyperplasia (AAH) to adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC), revealing that perturbed metabolic pathways emerge early in premalignant lesions. Furthermore, three panels of plasma metabolites are identified as non-invasive predictive biomarkers to distinguish IAC and its precursors with benign diseases. Strikingly, metabolomics clustering defines three metabolic subtypes of IAC patients with distinct clinical characteristics. We identify correlation between aberrant bile acid metabolism in subtype III with poor clinical features and demonstrate dysregulated bile acid metabolism promotes migration of LUAD, which could be exploited as potential targetable vulnerability and for stratifying patients. Collectively, the comprehensive landscape of the metabolic evolution along the development of LUAD will improve early detection and provide impactful therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41467-021-26685-y","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T11:05:20Z","timestamp":1636542320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2267-5810","authenticated-orcid":false,"given":"Meng","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2638-2978","authenticated-orcid":false,"given":"Ke","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5936-607X","authenticated-orcid":false,"given":"Xinsheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8460-6875","authenticated-orcid":false,"given":"Na","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6966-6631","authenticated-orcid":false,"given":"Nan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4196-2305","authenticated-orcid":false,"given":"Bo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7158-1629","authenticated-orcid":false,"given":"LiAng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1771-7545","authenticated-orcid":false,"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4146-7750","authenticated-orcid":false,"given":"Zeping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"26685_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"26685_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen, Z., Fillmore, C. M., Hammerman, P. S., Kim, C. F. & Wong, K. K. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat. Rev. Cancer 14, 535\u2013546 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"26685_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/MCP.0000000000000065","volume":"20","author":"W Weichert","year":"2014","unstructured":"Weichert, W. & Warth, A. Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma. Curr. Opin. Pulm. Med. 20, 309\u2013316 (2014).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"26685_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"National Lung Screening Trial Research, T.","year":"2011","unstructured":"National Lung Screening Trial Research, T. et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365, 395\u2013409 (2011).","journal-title":"N. Engl. J. Med."},{"key":"26685_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10877-8","volume":"10","author":"X Hu","year":"2019","unstructured":"Hu, X. et al. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat. Commun. 10, 2978 (2019).","journal-title":"Nat. Commun."},{"key":"26685_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13460-3","volume":"10","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. Genomic and immune profiling of pre-invasive lung adenocarcinoma. Nat. Commun. 10, 5472 (2019).","journal-title":"Nat. Commun."},{"key":"26685_CR7","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.jtho.2019.07.031","volume":"14","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Genomic landscape and immune microenvironment features of preinvasive and early invasive lung adenocarcinoma. J. Thorac. Oncol. 14, 1912\u20131923 (2019).","journal-title":"J. Thorac. Oncol."},{"key":"26685_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10879-6","volume":"10","author":"S Devarakonda","year":"2019","unstructured":"Devarakonda, S. & Govindan, R. Untangling the evolutionary roots of lung cancer. Nat. Commun. 10, 2979 (2019).","journal-title":"Nat. Commun."},{"key":"26685_CR9","doi-asserted-by":"publisher","unstructured":"Xing, X. et al. Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing. Sci Adv 7, https:\/\/doi.org\/10.1126\/sciadv.abd9738 (2021).","DOI":"10.1126\/sciadv.abd9738"},{"key":"26685_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22890-x","volume":"12","author":"H Dejima","year":"2021","unstructured":"Dejima, H. et al. Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features. Nat. Commun. 12, 2722 (2021).","journal-title":"Nat. Commun."},{"key":"26685_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40170-016-0156-6","volume":"4","author":"MA Keibler","year":"2016","unstructured":"Keibler, M. A. et al. Metabolic requirements for cancer cell proliferation. Cancer Metab. 4, 16 (2016).","journal-title":"Cancer Metab."},{"key":"26685_CR12","doi-asserted-by":"publisher","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, https:\/\/doi.org\/10.1126\/science.aaw5473 (2020).","DOI":"10.1126\/science.aaw5473"},{"key":"26685_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccell.2015.12.004","volume":"29","author":"AA Hakimi","year":"2016","unstructured":"Hakimi, A. A. et al. An integrated metabolic atlas of clear cell renal cell carcinoma. Cancer Cell 29, 104\u2013116 (2016).","journal-title":"Cancer Cell"},{"key":"26685_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","volume":"25","author":"S Yachida","year":"2019","unstructured":"Yachida, S. et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat. Med. 25, 968\u2013976 (2019).","journal-title":"Nat. Med."},{"key":"26685_CR15","doi-asserted-by":"publisher","unstructured":"Scafoglio, C. R. et al. Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma. Sci Transl Med 10, https:\/\/doi.org\/10.1126\/scitranslmed.aat5933 (2018).","DOI":"10.1126\/scitranslmed.aat5933"},{"key":"26685_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41591-019-0423-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Methionine is a metabolic dependency of tumor-initiating cells. Nat. Med. 25, 825\u2013837 (2019).","journal-title":"Nat. Med."},{"key":"26685_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrc3557","volume":"13","author":"JW Locasale","year":"2013","unstructured":"Locasale, J. W. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 13, 572\u2013583 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"26685_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41568-019-0187-8","volume":"19","author":"SM Sanderson","year":"2019","unstructured":"Sanderson, S. M., Gao, X., Dai, Z. & Locasale, J. W. Methionine metabolism in health and cancer: a nexus of diet and precision medicine. Nat. Rev. Cancer 19, 625\u2013637 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"26685_CR19","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1056\/NEJMoa1209120","volume":"368","author":"National Lung Screening Trial Research, T.","year":"2013","unstructured":"National Lung Screening Trial Research, T. et al. Results of initial low-dose computed tomographic screening for lung cancer. N. Engl. J. Med 368, 1980\u20131991 (2013).","journal-title":"N. Engl. J. Med"},{"key":"26685_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","volume":"382","author":"HJ de Koning","year":"2020","unstructured":"de Koning, H. J. et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N. Engl. J. Med. 382, 503\u2013513 (2020).","journal-title":"N. Engl. J. Med."},{"key":"26685_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen, J. D. et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359, 926\u2013930 (2018).","journal-title":"Science"},{"key":"26685_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4755-1","volume":"18","author":"K Vanhove","year":"2018","unstructured":"Vanhove, K. et al. The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer. BMC Cancer 18, 868 (2018).","journal-title":"BMC Cancer"},{"key":"26685_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","volume":"182","author":"JY Xu","year":"2020","unstructured":"Xu, J. Y. et al. Integrative proteomic characterization of human lung adenocarcinoma. Cell 182, 245\u2013261 e217 (2020).","journal-title":"Cell"},{"key":"26685_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cell.2020.06.012","volume":"182","author":"YJ Chen","year":"2020","unstructured":"Chen, Y. J. et al. Proteogenomics of non-smoking lung cancer in east asia delineates molecular signatures of pathogenesis and progression. Cell 182, 226\u2013244 e217 (2020).","journal-title":"Cell"},{"key":"26685_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette, M. A. et al. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182, 200\u2013225 e235 (2020).","journal-title":"Cell"},{"key":"26685_CR26","doi-asserted-by":"publisher","unstructured":"Ma, C. et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360, https:\/\/doi.org\/10.1126\/science.aan5931 (2018).","DOI":"10.1126\/science.aan5931"},{"key":"26685_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41579-018-0053-9","volume":"16","author":"A Dart","year":"2018","unstructured":"Dart, A. Gut microbiota bile acid metabolism controls cancer immunosurveillance. Nat. Rev. Microbiol 16, 453 (2018).","journal-title":"Nat. Rev. Microbiol"},{"key":"26685_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia, W., Xie, G. & Jia, W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat. Rev. Gastroenterol. Hepatol. 15, 111\u2013128 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"26685_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3389\/fphys.2016.00646","volume":"7","author":"C Guo","year":"2016","unstructured":"Guo, C., Chen, W. D. & Wang, Y. D. TGR5, not only a metabolic regulator. Front Physiol. 7, 646 (2016).","journal-title":"Front Physiol."},{"key":"26685_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/10799893.2013.802805","volume":"33","author":"V Stepanov","year":"2013","unstructured":"Stepanov, V., Stankov, K. & Mikov, M. The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders. J. Recept Signal Transduct. Res. 33, 213\u2013223 (2013).","journal-title":"J. Recept Signal Transduct. Res."},{"key":"26685_CR31","first-page":"3567","volume":"11","author":"RY Zhao","year":"2018","unstructured":"Zhao, R. Y. et al. High expression of TGR5 predicts a poor prognosis in patients with pancreatic cancer. Int J. Clin. Exp. Pathol. 11, 3567\u20133574 (2018).","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"26685_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","volume":"21","author":"AW Lambert","year":"2021","unstructured":"Lambert, A. W. & Weinberg, R. A. Linking EMT programmes to normal and neoplastic epithelial stem cells. Nat. Rev. Cancer 21, 325\u2013338 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"26685_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69\u201384 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"26685_CR34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2147\/DDDT.S131892","volume":"11","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animals. Drug Des. Devel Ther. 11, 1127\u20131134 (2017).","journal-title":"Drug Des. Devel Ther."},{"key":"26685_CR35","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","volume":"25","author":"X Qi","year":"2019","unstructured":"Qi, X. et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat. Med. 25, 1225\u20131233 (2019).","journal-title":"Nat. Med"},{"key":"26685_CR36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.aav0173","volume":"363","author":"CK Lee","year":"2019","unstructured":"Lee, C. K. et al. Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation. Science 363, 644\u2013649 (2019).","journal-title":"Science"},{"key":"26685_CR37","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/hep.25797","volume":"56","author":"B Nie","year":"2012","unstructured":"Nie, B. et al. Specific bile acids inhibit hepatic fatty acid uptake in mice. Hepatology 56, 1300\u20131310 (2012).","journal-title":"Hepatology"},{"key":"26685_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/pop.2009.0010","volume":"13","author":"SW Goldberg","year":"2010","unstructured":"Goldberg, S. W., Mulshine, J. L., Hagstrom, D. & Pyenson, B. S. An actuarial approach to comparing early stage and late stage lung cancer mortality and survival. Popul Health Manag 13, 33\u201346 (2010).","journal-title":"Popul Health Manag"},{"key":"26685_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","volume":"15","author":"MO Yuneva","year":"2012","unstructured":"Yuneva, M. O. et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab. 15, 157\u2013170 (2012).","journal-title":"Cell Metab."},{"key":"26685_CR40","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","volume":"164","author":"CT Hensley","year":"2016","unstructured":"Hensley, C. T. et al. Metabolic heterogeneity in human lung tumors. Cell 164, 681\u2013694 (2016).","journal-title":"Cell"},{"key":"26685_CR41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-019-1330-0","volume":"571","author":"C Mascaux","year":"2019","unstructured":"Mascaux, C. et al. Immune evasion before tumour invasion in early lung squamous carcinogenesis. Nature 571, 570\u2013575 (2019).","journal-title":"Nature"},{"key":"26685_CR42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41586-019-1437-3","volume":"572","author":"X Gao","year":"2019","unstructured":"Gao, X. et al. Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature 572, 397\u2013401 (2019).","journal-title":"Nature"},{"key":"26685_CR43","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.bbalip.2018.06.015","volume":"1863","author":"EA Triantafyllou","year":"2018","unstructured":"Triantafyllou, E. A., Georgatsou, E., Mylonis, I., Simos, G. & Paraskeva, E. Expression of AGPAT2, an enzyme involved in the glycerophospholipid\/triacylglycerol biosynthesis pathway, is directly regulated by HIF-1 and promotes survival and etoposide resistance of cancer cells under hypoxia. Biochim Biophys. Acta Mol. Cell Biol. Lipids 1863, 1142\u20131152 (2018).","journal-title":"Biochim Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"26685_CR44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/1874467211104030167","volume":"4","author":"V Dolce","year":"2011","unstructured":"Dolce, V., Cappello, A. R., Lappano, R. & Maggiolini, M. Glycerophospholipid synthesis as a novel drug target against cancer. Curr. Mol. Pharm. 4, 167\u2013175 (2011).","journal-title":"Curr. Mol. Pharm."},{"key":"26685_CR45","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.ccell.2017.08.008","volume":"32","author":"SK Shukla","year":"2017","unstructured":"Shukla, S. K. et al. MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer. Cancer Cell 32, 392 (2017).","journal-title":"Cancer Cell"},{"key":"26685_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09834-2","volume":"10","author":"JE Beane","year":"2019","unstructured":"Beane, J. E. et al. Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions. Nat. Commun. 10, 1856 (2019).","journal-title":"Nat. Commun."},{"key":"26685_CR47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41586-020-2140-0","volume":"580","author":"JJ Chabon","year":"2020","unstructured":"Chabon, J. J. et al. Integrating genomic features for non-invasive early lung cancer detection. Nature 580, 245\u2013251 (2020).","journal-title":"Nature"},{"key":"26685_CR48","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1021\/acs.jproteome.9b00287","volume":"18","author":"B Geary","year":"2019","unstructured":"Geary, B. et al. Identification of a biomarker panel for early detection of lung cancer patients. J. Proteome Res. 18, 3369\u20133382 (2019).","journal-title":"J. Proteome Res"},{"key":"26685_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","volume":"37","author":"J Xiong","year":"2020","unstructured":"Xiong, J. et al. Genomic and transcriptomic characterization of natural killer T cell lymphoma. Cancer Cell 37, 403\u2013419 e406 (2020).","journal-title":"Cancer Cell"},{"key":"26685_CR50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","volume":"179","author":"Q Gao","year":"2019","unstructured":"Gao, Q. et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell 179, 561\u2013577 e522 (2019).","journal-title":"Cell"},{"key":"26685_CR51","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","volume":"177","author":"S Vasaikar","year":"2019","unstructured":"Vasaikar, S. et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell 177, 1035\u20131049 e1019 (2019).","journal-title":"Cell"},{"key":"26685_CR52","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2019.01.036","volume":"176","author":"T Fu","year":"2019","unstructured":"Fu, T. et al. FXR regulates intestinal cancer stem cell proliferation. Cell 176, 1098\u20131112 e1018 (2019).","journal-title":"Cell"},{"key":"26685_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.canlet.2019.04.009","volume":"454","author":"L Gao","year":"2019","unstructured":"Gao, L. et al. Glycochenodeoxycholate promotes hepatocellular carcinoma invasion and migration by AMPK\/mTOR dependent autophagy activation. Cancer Lett. 454, 215\u2013223 (2019).","journal-title":"Cancer Lett."},{"key":"26685_CR54","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst, R. S., Morgensztern, D. & Boshoff, C. The biology and management of non-small cell lung cancer. Nature 553, 446\u2013454 (2018).","journal-title":"Nature"},{"key":"26685_CR55","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1172\/JCI96268","volume":"128","author":"P Jayaprakash","year":"2018","unstructured":"Jayaprakash, P. et al. Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy. J. Clin. Invest 128, 5137\u20135149 (2018).","journal-title":"J. Clin. Invest"},{"key":"26685_CR56","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.aav2588","volume":"366","author":"RD Leone","year":"2019","unstructured":"Leone, R. D. et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science 366, 1013\u20131021 (2019).","journal-title":"Science"},{"key":"26685_CR57","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1172\/JCI69589","volume":"123","author":"M Sukumar","year":"2013","unstructured":"Sukumar, M. et al. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Invest 123, 4479\u20134488 (2013).","journal-title":"J. Clin. Invest"},{"key":"26685_CR58","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1056\/NEJMcibr1914890","volume":"382","author":"RJ DeBerardinis","year":"2020","unstructured":"DeBerardinis, R. J. Tumor microenvironment, metabolism, and immunotherapy. N. Engl. J. Med. 382, 869\u2013871 (2020).","journal-title":"N. Engl. J. Med"},{"key":"26685_CR59","doi-asserted-by":"publisher","unstructured":"DePeaux, K. & Delgoffe, G. M. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol, https:\/\/doi.org\/10.1038\/s41577-021-00541-y (2021).","DOI":"10.1038\/s41577-021-00541-y"},{"key":"26685_CR60","doi-asserted-by":"publisher","unstructured":"Najjar, Y. G. et al. Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma. JCI Insight 4, https:\/\/doi.org\/10.1172\/jci.insight.124989 (2019).","DOI":"10.1172\/jci.insight.124989"},{"key":"26685_CR61","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","volume":"167","author":"R Geiger","year":"2016","unstructured":"Geiger, R. et al. L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167, 829\u2013842 e813 (2016).","journal-title":"Cell"},{"key":"26685_CR62","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMcibr1807106","volume":"379","author":"C Schramm","year":"2018","unstructured":"Schramm, C. Bile acids, the microbiome, immunity, and liver tumors. N. Engl. J. Med. 379, 888\u2013890 (2018).","journal-title":"N. Engl. J. Med"},{"key":"26685_CR63","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1021\/ac051495j","volume":"78","author":"S Bijlsma","year":"2006","unstructured":"Bijlsma, S. et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal. Chem. 78, 567\u2013574 (2006).","journal-title":"Anal. Chem."},{"key":"26685_CR64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ab.2016.03.011","volume":"503","author":"JJ Zheng","year":"2016","unstructured":"Zheng, J. J. et al. The utility of stable isotope labeled (SIL) analogues in the bioanalysis of endogenous compounds by LC-MS applied to the study of bile acids in a metabolomics assay. Anal. Biochem 503, 71\u201378 (2016).","journal-title":"Anal. Biochem"},{"key":"26685_CR65","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"26685_CR66","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26685-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26685-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26685-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T13:02:25Z","timestamp":1721221345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26685-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["26685"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-26685-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"2 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6479"}}